M Weber

770 total citations
33 papers, 426 citations indexed

About

M Weber is a scholar working on Epidemiology, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, M Weber has authored 33 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 5 papers in Psychiatry and Mental health and 4 papers in Infectious Diseases. Recurrent topics in M Weber's work include Respiratory viral infections research (6 papers), Pneumonia and Respiratory Infections (4 papers) and Epilepsy research and treatment (4 papers). M Weber is often cited by papers focused on Respiratory viral infections research (6 papers), Pneumonia and Respiratory Infections (4 papers) and Epilepsy research and treatment (4 papers). M Weber collaborates with scholars based in Mexico, France and Belgium. M Weber's co-authors include Rezaul Karim, R. Reife, Gordon Pledger, M. K. Sharief, Elinor Ben‐Menachem, C. Viteri, R Poiré, J Courjon, H Gastaut and Bruce L. Innis and has published in prestigious journals such as The Journal of Infectious Diseases, Epilepsia and The Pediatric Infectious Disease Journal.

In The Last Decade

M Weber

31 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Weber Mexico 9 205 171 132 108 33 33 426
Sherian Xu Li United States 7 151 0.7× 109 0.6× 113 0.9× 38 0.4× 33 1.0× 8 373
Owais Khan United States 11 217 1.1× 225 1.3× 274 2.1× 34 0.3× 141 4.3× 41 597
J. F. Schoeman South Africa 19 79 0.4× 99 0.6× 197 1.5× 85 0.8× 377 11.4× 36 895
Mary Buckwalter United States 12 119 0.6× 59 0.3× 46 0.3× 56 0.5× 213 6.5× 14 543
P. Satishchandra India 7 108 0.5× 50 0.3× 58 0.4× 28 0.3× 83 2.5× 10 350
Takanori Funaki Japan 11 116 0.6× 29 0.2× 143 1.1× 109 1.0× 145 4.4× 51 456
Charlotte M. Anderson Australia 17 60 0.3× 140 0.8× 44 0.3× 33 0.3× 31 0.9× 43 730
Raquel Farias‐Moeller United States 10 368 1.8× 177 1.0× 26 0.2× 96 0.9× 204 6.2× 25 542
A. A. Olumide Nigeria 6 240 1.2× 255 1.5× 30 0.2× 46 0.4× 48 1.5× 15 435
Marisela Palacios Reyes United States 11 183 0.9× 26 0.2× 86 0.7× 19 0.2× 18 0.5× 14 423

Countries citing papers authored by M Weber

Since Specialization
Citations

This map shows the geographic impact of M Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Weber more than expected).

Fields of papers citing papers by M Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Weber. The network helps show where M Weber may publish in the future.

Co-authorship network of co-authors of M Weber

This figure shows the co-authorship network connecting the top 25 collaborators of M Weber. A scholar is included among the top collaborators of M Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Weber. M Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weber, M, et al.. (2018). Economic burden of varicella complications in two referral centers in Mexico. Human Vaccines & Immunotherapeutics. 14(12). 2950–2954. 6 indexed citations
3.
Weber, M, Carine Claeys, Yang Feng, et al.. (2014). Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age. The Pediatric Infectious Disease Journal. 33(12). 1262–1269. 16 indexed citations
4.
Langley, Joanne M., Archana Chatterjee, Scott A. Halperin, et al.. (2013). Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children. The Journal of Infectious Diseases. 208(4). 544–553. 51 indexed citations
5.
Pavía-Ruz, Noris, M Weber, YL Lau, et al.. (2013). A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age. Human Vaccines & Immunotherapeutics. 9(9). 1978–1988. 19 indexed citations
6.
Cherry, James D., Ángela Gentile, M Weber, et al.. (2011). Consenso para el diagnóstico clínico y microbiológico y la prevención de la infección por Bordetella pertussis. Salud Pública de México. 53(1). 57–65. 11 indexed citations
7.
Ritchie, Lisa M. Puchalski, et al.. (2009). Long-term morbidity from severe pneumonia in early childhood in The Gambia, West Africa: a follow-up study.. PubMed. 13(4). 527–32. 20 indexed citations
8.
Gutiérrez‐Castrellón, Pedro, et al.. (2007). Complicaciones de la ventilación mecánica en neonatos. Acta Pediátrica de México. 28(2). 63–68. 6 indexed citations
9.
Weber, M, et al.. (2003). Morbilidad y mortalidad por sepsis neonatal en un hospital de tercer nivel de atención. 13 indexed citations
10.
Weber, M, et al.. (2003). Morbidity and mortality due to neonatal sepsis in a tertiary care hospital. Salud Pública de México. 45(2). 90–5. 4 indexed citations
11.
Weber, M, et al.. (2002). Factores que influyen en la extracción sanguínea a pacientes hospitalizados en una terapia intensiva neonatal. Boletín Médico del Hospital Infantil de México. 59(3). 159–165. 1 indexed citations
12.
Weber, M, et al.. (2002). Eficacia y seguridad de rifaximina en el tratamiento del episodio diarreico agudo en niños de seis meses a cinco años. 15(61). 23–28. 5 indexed citations
13.
Weber, M, et al.. (2001). Aislamiento bacteriológico en neonatos con datos clínicos de sepsis en un hospital pediátrico. 14(55). 78–84. 1 indexed citations
14.
Granel, F, Emmanuel de Maistre, Bruno Challier, M Weber, & Schmutz Jl. (1998). Accident vasculaire cérébral du sujet jeune et/ou livedo: y a-t-il un intérêt à rechercher les anticorps anti-β2-glycoprotéine I?. La Revue de Médecine Interne. 19(10). 709–712. 2 indexed citations
15.
Sharief, M. K., C. Viteri, Elinor Ben‐Menachem, et al.. (1996). Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Research. 25(3). 217–224. 144 indexed citations
16.
Jouanny, P., Hervé Vespignani, A. Gérard, et al.. (1994). Méningoencéphalite herpétique du sujet âgé. À propos de 13 observations. La Revue de Médecine Interne. 15(8). 504–509. 6 indexed citations
17.
Vespignani, Hervé, et al.. (1986). Interet du mazindol dans la maladie de Gelineau. A propos de 10 observations. Revue d Electroencé phalographie et de Neurophysiologie Clinique. 16(3). 317–322. 5 indexed citations
18.
Weber, M, et al.. (1982). [Securing the ABO-identity by serafol before blood transfusions (author's transl)].. PubMed. 31(4). 204–5. 1 indexed citations
19.
Vespignani, Hervé, Bernard Legras, M Weber, et al.. (1981). Frequence et evolution semeiologique des crises epileptiques apparues entre 40 et 65 ans. Revue d Electroencé phalographie et de Neurophysiologie Clinique. 11(3-4). 524–530. 1 indexed citations
20.
Gastaut, H, J Courjon, R Poiré, & M Weber. (1971). Treatment of Status Epilepticus with a new Benzodiazepine More Active than Diazepam*. Epilepsia. 12(3). 197–214. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherian Xu Li Breakdown of academic impact, for papers by Owais Khan Breakdown of academic impact, for papers by J. F. Schoeman Breakdown of academic impact, for papers by Mary Buckwalter Breakdown of academic impact, for papers by P. Satishchandra Breakdown of academic impact, for papers by Takanori Funaki Breakdown of academic impact, for papers by Charlotte M. Anderson Breakdown of academic impact, for papers by Raquel Farias‐Moeller Breakdown of academic impact, for papers by A. A. Olumide Breakdown of academic impact, for papers by Marisela Palacios Reyes
Rankless by CCL
2026